Trexquant Investment’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-32,930
Closed -$838K 1552
2024
Q3
$838K Buy
+32,930
New +$838K 0.01% 1102
2023
Q4
Sell
-9,216
Closed -$243K 1428
2023
Q3
$243K Buy
+9,216
New +$243K 0.01% 1294
2023
Q1
Sell
-143,067
Closed -$1.09M 1440
2022
Q4
$1.09M Sell
143,067
-11,023
-7% -$84K 0.03% 615
2022
Q3
$1.53M Buy
154,090
+91,210
+145% +$907K 0.05% 410
2022
Q2
$571K Buy
+62,880
New +$571K 0.03% 753
2021
Q4
Sell
-29,204
Closed -$1.37M 1292
2021
Q3
$1.37M Buy
29,204
+22,638
+345% +$1.06M 0.11% 252
2021
Q2
$400K Buy
6,566
+1,696
+35% +$103K 0.03% 590
2021
Q1
$300K Buy
+4,870
New +$300K 0.03% 749
2020
Q4
Sell
-12,906
Closed -$484K 1025
2020
Q3
$484K Sell
12,906
-8,812
-41% -$330K 0.03% 702
2020
Q2
$708K Buy
+21,718
New +$708K 0.05% 533